Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Insights into clonal and CBC changes at disease evolution among ccus patients

Yazan Jabban, Rong He, Kurt Bessonen, Patricia Greipp, Dragan Jevremovic, David Viswanatha, James Foran, Talha Badar, Cecilia Arana Yi, Yael Kusne, Antoine Saliba, Mehrdad Hefazi Torghabeh, Aasiya Matin, William Hogan, Abhishek Mangaonkar, Mithun Shah, Hassan Alkhateeb, Mrinal Patnaik, Aref Al-Kali

Blood (2025) 146 (Supplement 1): 5621.

https://doi.org/10.1182/blood-2025-5621

Published: 2025

Journal Articles

Blast clearance dynamics and time to response across IDH1- and IDH2-mutated AML

Blood (2025) 146 (Supplement 1): 7045.

https://doi.org/10.1182/blood-2025-7045

Published: 2025

Journal Articles

Spatial multiomics reveal a critical role for TIM4-expressing macrophages in blast transformation of chronic myelomonocytic leukemia

Abhishek Mangaonkar, Justin Boysen, Terra Lasho, Christy Finke, Jenna Fernandez, Jose Villasboas Bisneto, Mehrdad Hefazi Torghabeh, Pankaj Pradeep, Will Sherman, Christy Trussoni, Tamas Ordog, Maha Rahim, Alejandro Ferrer, Kaaren Reichard, Mrinal Patnaik

Blood (2025) 146 (Supplement 1): 3831.

https://doi.org/10.1182/blood-2025-3831

Published: 2025

Journal Articles

Remodeling the bone marrow tumor microenvironment with CART cell therapy to overcome resistance in multiple myeloma

Blood (2025) 146 (Supplement 1): 1028.

https://doi.org/10.1182/blood-2025-1028

Published: 2025

Journal Articles

Molecular association with elevated LDH levels in patients with AML

Oudai Alkabbani, Yazan Jabban, Rong He, David Viswanatha, Kurt Bessonen, Patricia Greipp, Dragan Jevremovic, Antoine Saliba, Mehrdad Hefazi Torghabeh, Aasiya Matin, William Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mrinal Patnaik, Mithun Shah, Kebede Begna, Aref Al-Kali

Blood (2025) 146 (Supplement 1): 7039.

https://doi.org/10.1182/blood-2025-7039

Published: 2025

Journal Articles

Overexpression of CD103 on regulatory T cells mitigates acute graft-versus-host disease via promotion of tolerogenic dendritic cell networks

Blood (2025) 146 (Supplement 1): 587.

https://doi.org/10.1182/blood-2025-587

Published: 2025

Journal Articles

Causes of death in DDX41-mutated myeloid neoplasms: A retrospective study

Blood (2025) 146 (Supplement 1): 7370.

https://doi.org/10.1182/blood-2025-7370

Published: 2025

Journal Articles

Fetal hemoglobin dysregulation in inherited and acquired bone marrow failure syndromes

Blood (2025) 146 (Supplement 1): 6750.

https://doi.org/10.1182/blood-2025-6750

Published: 2025

Journal Articles

Live imaging of human xenogeneic CART cells in a clinical trial of companion dogs with lymphoma

Blood (2025) 146 (Supplement 1): 4105.

https://doi.org/10.1182/blood-2025-4105

Published: 2025

Journal Articles

Ibrutinib enhances 41BB-costimulated CART19 function and persistence through immune reprogramming: Insights from the phase 3 ECOG-ACRIN E1912 clinical Trial

Blood (2025) 146 (Supplement 1): 2101.

https://doi.org/10.1182/blood-2025-2101

Published: 2025

Journal Articles

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

Blood (2025) 146 (Supplement 1): 2087.

https://doi.org/10.1182/blood-2025-2087

Published: 2025

Journal Articles

The need for re-induction based on D14-residual acute myeloid leukemia in patients achieving complete remission predicts higher relapse rate and inferior post-remission survival

Blood (2025) 146 (Supplement 1): 1605.

https://doi.org/10.1182/blood-2025-1605

Published: 2025

Journal Articles

CPX-351 versus venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia: A comparative analysis of outcomes in 600 patients

Blood (2025) 146 (Supplement 1): 1602.

https://doi.org/10.1182/blood-2025-1602

Published: 2025

Journal Articles

Targeting CSF1R to overcome myeloid cell suppression in CART therapy

Blood (2025) 146 (Supplement 1): 5883.

https://doi.org/10.1182/blood-2025-5883

Published: 2025

Journal Articles

Molecular stratification of relapse risk post-allogeneic hematopoietic stem cell transplantation in myeloid neoplasms with non-adverse risk cytogenetics

Khalid Abu-Zeinah, Anmol Baranwal, Khalil Hassan, Al Rabee Kassis, Aasiya Matin, Mehrdad Hefazi Torghabeh, Abhishek Mangaonkar, Mark Litzow, William Hogan, Mithun Shah, David Dingli, Hassan Alkhateeb

Blood (2025) 146 (Supplement 1): 6073.

https://doi.org/10.1182/blood-2025-6073

Published: 2025

Journal Articles

IL-4 epigenetically reprograms CART19-28ζ cells to drive dysfunction

Blood (2025) 146 (Supplement 1): 2338.

https://doi.org/10.1182/blood-2025-2338

Published: 2025

Journal Articles

The synonymous IDH1 p.Gly105Gly (rs11554137) variant associates with AML post-transplant relapse via aberrant signal transduction pathways

Blood (2025) 146 (Supplement 1): 1699.

https://doi.org/10.1182/blood-2025-1699

Published: 2025

Journal Articles

Treatment-specific prognostic performance of ELN 2022, ELN 2024, and beat AML 2024: A real-world AML validation study

Tariq Kewan, Oudai Alkabbani, Rong He, Dragan Jevremovic, Patricia Greipp, Antoine Saliba, Aasiya Matin, Mehrdad Hefazi Torghabeh, Abhishek Mangaonkar, Naseema Gangat, William Hogan, Mrinal Patnaik, Hassan Alkhateeb, Cecilia Arana Yi, James Foran, Mark Litzow, Mithun Shah, Kebede Begna, Aref Al-Kali

Blood (2025) 146 (Supplement 1): 996.

https://doi.org/10.1182/blood-2025-996

Published: 2025

Journal Articles

Upfront therapy with allogeneic hematopoietic stem cell transplantation versus DNA methyltransferase inhibitors in patients with vexas syndrome: A comparative matched cohort efficacy analysis of 39 patients

Blood (2025) 146 (Supplement 1): 981.

https://doi.org/10.1182/blood-2025-981

Published: 2025

Journal Articles

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Mehrdad Hefazi Torghabeh, MD, Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Raymund Razonable, MD, Aref Al-Kali, MD, Shahrukh K. Hashmi, MD, William J Hogan, MD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 1913.

https://doi.org/10.1182/blood.V126.23.1913.1913

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Insights into clonal and CBC changes at disease evolution among ccus patients

Blast clearance dynamics and time to response across IDH1- and IDH2-mutated AML

Spatial multiomics reveal a critical role for TIM4-expressing macrophages in blast transformation of chronic myelomonocytic leukemia

Remodeling the bone marrow tumor microenvironment with CART cell therapy to overcome resistance in multiple myeloma

Molecular association with elevated LDH levels in patients with AML

Overexpression of CD103 on regulatory T cells mitigates acute graft-versus-host disease via promotion of tolerogenic dendritic cell networks

Causes of death in DDX41-mutated myeloid neoplasms: A retrospective study

Fetal hemoglobin dysregulation in inherited and acquired bone marrow failure syndromes

Live imaging of human xenogeneic CART cells in a clinical trial of companion dogs with lymphoma

Ibrutinib enhances 41BB-costimulated CART19 function and persistence through immune reprogramming: Insights from the phase 3 ECOG-ACRIN E1912 clinical Trial

Integrated prognostic model for TP53‑mutated myeloid neoplasms across all myeloid neoplasm subtypes

The need for re-induction based on D14-residual acute myeloid leukemia in patients achieving complete remission predicts higher relapse rate and inferior post-remission survival

CPX-351 versus venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia: A comparative analysis of outcomes in 600 patients

Targeting CSF1R to overcome myeloid cell suppression in CART therapy

Molecular stratification of relapse risk post-allogeneic hematopoietic stem cell transplantation in myeloid neoplasms with non-adverse risk cytogenetics

IL-4 epigenetically reprograms CART19-28ζ cells to drive dysfunction

The synonymous IDH1 p.Gly105Gly (rs11554137) variant associates with AML post-transplant relapse via aberrant signal transduction pathways

Treatment-specific prognostic performance of ELN 2022, ELN 2024, and beat AML 2024: A real-world AML validation study

Upfront therapy with allogeneic hematopoietic stem cell transplantation versus DNA methyltransferase inhibitors in patients with vexas syndrome: A comparative matched cohort efficacy analysis of 39 patients

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only